Tacalyx.

Tacalyx

Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist

Tacalyx company information

Edit
Growth stage
Edit
Tacalyx team Edit
Are you an employee or an investor of this company?
Add your profile